Summit Investment Advisors, Inc.\KS’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76M Sell
2,387
-16
-0.7% -$18.9K 1.25% 15
2026
Q2
$2.88M Sell
2,403
-8
-0.3% -$8.17K 1.32% 18
2026
Q1
$2.22M Sell
2,411
-12
-0.5% -$12.2K 1.13% 23
2025
Q4
$2.6M Buy
+2,423
New +$2.32M 1.4% 20

Other funds holding LLY

Summit Investment Advisors, Inc.\KS's LLY Position: Q3 2026 in Review

Summit Investment Advisors, Inc.\KS reduced its Eli Lilly (LLY) stake by 0.67% in Q3 2026, selling an estimated $18.9K and leaving 2,387 shares worth $2.76M. The position accounts for 1.25% of the portfolio, ranked #15.

Summit Investment Advisors, Inc.\KS first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.88M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Summit Investment Advisors, Inc.\KS held 2,387 shares of Eli Lilly worth $2.76M as of Q3 2026.
  • Summit Investment Advisors, Inc.\KS sold 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
  • Eli Lilly made up 1.25% of Summit Investment Advisors, Inc.\KS's portfolio in Q3 2026, its #15 holding.
  • Summit Investment Advisors, Inc.\KS first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Summit Investment Advisors, Inc.\KS's Eli Lilly position peaked at $2.88M in Q2 2026.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Summit Investment Advisors, Inc.\KS's 13F filing for Q3 2026, filed 5 Nov 2026.